Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$0.63 - $1.14 $8,734 - $15,806
-13,865 Reduced 15.75%
74,158 $61,000
Q3 2023

Oct 31, 2023

BUY
$1.12 - $1.88 $7,739 - $12,990
6,910 Added 8.52%
88,023 $99,000
Q2 2023

Jul 19, 2023

SELL
$1.31 - $2.04 $4,450 - $6,929
-3,397 Reduced 4.02%
81,113 $130,000
Q1 2023

May 12, 2023

BUY
$1.45 - $2.95 $10,115 - $20,579
6,976 Added 9.0%
84,510 $128,000
Q4 2022

Feb 10, 2023

SELL
$2.02 - $3.25 $4,290 - $6,903
-2,124 Reduced 2.67%
77,534 $186,000
Q3 2022

Nov 03, 2022

BUY
$1.96 - $3.14 $91,075 - $145,906
46,467 Added 140.0%
79,658 $163,000
Q2 2022

Aug 09, 2022

SELL
$1.3 - $2.64 $12,298 - $24,974
-9,460 Reduced 22.18%
33,191 $64,000
Q1 2022

May 09, 2022

BUY
$2.35 - $3.47 $17,100 - $25,251
7,277 Added 20.57%
42,651 $105,000
Q4 2021

Feb 10, 2022

BUY
$2.92 - $5.74 $27,334 - $53,732
9,361 Added 35.99%
35,374 $114,000
Q3 2021

Nov 09, 2021

BUY
$4.98 - $6.63 $46,772 - $62,268
9,392 Added 56.51%
26,013 $137,000
Q2 2021

Aug 05, 2021

BUY
$2.56 - $5.49 $7,150 - $15,333
2,793 Added 20.2%
16,621 $91,000
Q1 2021

May 11, 2021

BUY
$2.69 - $5.25 $7,615 - $14,862
2,831 Added 25.74%
13,828 $38,000
Q4 2020

Feb 11, 2021

BUY
$3.17 - $4.49 $34,860 - $49,376
10,997 New
10,997 $35,000
Q4 2018

Mar 04, 2019

SELL
$1.59 - $2.66 $16,275 - $27,227
-10,236 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$1.59 - $2.42 $10,067 - $15,323
-6,332 Reduced 38.22%
10,236 $22,000
Q2 2018

Aug 06, 2018

SELL
$2.26 - $4.65 $7,566 - $15,568
-3,348 Reduced 16.81%
16,568 $38,000
Q1 2018

May 08, 2018

SELL
$3.51 - $6.04 $34,987 - $60,206
-9,968 Reduced 33.36%
19,916 $94,000
Q4 2017

Feb 06, 2018

BUY
$3.26 - $4.78 $97,421 - $142,845
29,884
29,884 $97,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.